Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study

NCT03903588 is registered in ClinicalTrials.gov with Heidelberg Engineering GmbH as lead sponsor.

NCT NCT03903588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03903588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Heidelberg Engineering SPECTRALIS Macular Precision and Agreement Study
Lead sponsor
Heidelberg Engineering GmbH
Phase
Observational
Overall status
Completed
Start date
March 22, 2019
Completion date
September 12, 2019
Enrollment
86 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

retinal layer separation